Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

MeCP2 and MBD2 expression during normal and pathological growth of the human mammary gland

Abstract

During the last years, a direct link between DNA methylation and repressive chromatin structure has been established. This structural modification is mediated by histone deacetylases targeted to the methylated sequences by Methyl Binding Proteins (MBD). Human cancer cells exhibit both a global hypomethylation and some localized hypermethylations suggesting that the deregulation of the methylation machinery is a central event in tumorigenesis. Therefore, we have investigated in human tissues the expression of two major MBDs, MeCP2 and MBD2, during the proliferation of normal breast and in benign and neoplasic breast tumors. Quantitation of the transcripts indicates that MBD2 mRNAs are 20–30-fold more abundant than MeCP2 transcripts in the adult and fetal human mammary gland. In pathological tissues samples MBD2 mRNA levels are significantly higher (P=0.001) in benign tumors compared with normal breast tissues, whereas MeCP2 expression is not modified in these specimens. In neoplasic samples a deregulation of the expression of both genes was found. The amounts of MBD2 and MeCP2 transcripts vary greatly between samples in cancer cells compared to normal breast tissues or benign tumors, and in invasive ductal carcinomas the amount of MBD2 mRNA is significantly (P=0.03) associated with the tumor size. Taken together these data suggest that upregulation of MBD2 might be associated with breast cell proliferation. In line with this hypothesis MBD2 is also upregulated during the prenatal development of the human mammary gland, but in contrast to that observed in tumor cells, MeCP2 is also coordinately upregulated in the fetal breast tissues, suggesting that deregulation of MeCP2 and MBD2 occurs in human breast cancers.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Arnaud M, Dante R, Niveauleau A . 1985 Biochem. Biophys. Res. Commun. 13: 108–112

  • Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP . 1997 Adv. Cancer Res. 72: 141–196

  • Bernardino J, Roux C, Almeida A, Vogt N, Gibaud A, Gerbault-Seureau M, Magdelenat H, Bourgeois CA, Malfoy B, Dutrillaux B . 1997 Cancer Genet. Cytogenet. 97: 83–89

  • Bird AP, Wolffe AP . 1999 Cell 99: 451–454

  • Chen RZ, Akbarian S, Tudor M, Jaenisch R . 2001 Nat. Genet. 27: 327–331

  • Costello JF, Fruhwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X, Wright FA, Feramisco JD, Peltomaki P, Lang JC, Schuller DE, Yu L, Bloomfield CD, Caligiuri MA, Yates A, Nishikawa R, Su Huang H, Petrelli NJ, Zhang X, O'Dorisio MS, Held WA, Cavenee WK, Plass C . 2000 Nat. Genet. 24: 132–138

  • Eads CA, Lord RV, Wickramasinghe K, Long TI, Kurumboor SK, Bernstein L, Peters JH, DeMeester SR, DeMeester TR, Skinner KA, Laird PW . 2001 Cancer Res. 61: 3410–3418

  • Ehrlich M . 2000 DNA Hypomethylation and Cancer in DNA Alterations in Cancer Ehrlich M (ed) Natich, MA: Eaton Publishing pp 273–291

    Google Scholar 

  • Guy J, Hendrich B, Holmes M, Martin JE, Bird A . 2001 Nat. Genet. 27: 322–326

  • Hendrich B, Bird A . 1998 Mol. Cell. Biol. 18: 6538–6547

  • Hendrich B, Guy J, Ramsahoye B, Wilson VA, Bird A . 2001 Genes Dev. 15: 710–723

  • Jones PL, Veenstra GJC, Wade PA, Vermaak D, Kass SU, Landsberger N, Stroboulis J, Wolffe AP . 1998 Nat. Genet. 19: 187–191

  • Kaludov NK, Wolffe AP . 2000 Nucleic Acids Res. 28: 1921–1928

  • Kanai Y, Ushijima S, Nakanishi Y, Hirohashi S . 1999 Biochem. Biophys. Res. Commun. 264: 962–966

  • Li E, Bestor TH, Jaenisch R . 1992 Cell 69: 915–926

  • Magdinier F, Dalla Venezia N, Lenoir GM, Frappart L, Dante R . 1999 Oncogene 18: 4039–4043

  • Magdinier F, Wolffe AP . 2001 Proc. Natl. Acad. Sci. USA 24: 4990–4995

  • Meehan RR, Lewis JD, Bird AP . 1992 Nucleic Acids Res. 11: 5085–5092

  • Meehan RR, Lewis JD, McKay S, Kleiner EL, Bird AP . 1989 Cell 58: 499–507

  • Nan X, Campoy FJ, Bird A . 1997 Cell 88: 471–481

  • Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN, Bird A . 1998 Nature 393: 386–389

  • Ng HH, Jeppesen P, Bird A . 2000 Mol. Cell. Biol. 20: 1394–1406

  • Ng HH, Zhang Y, Hendrich B, Johnson CA, Turner BM, Erdjument-Bromage H, Tempst P, Reinberg D, Bird A . 1999 Nat. Genet. 23: 58–61

  • Poulsen HE, Taylor CW, Sobin LH . 1975 Histological typing of female genital tract tumors International histological classification of tumors World Health Organization, Geneva 13

    Google Scholar 

  • Ribieras S, Magdinier F, Leclerc D, Lenoir G, Frappart L, Dante R . 1997 Int. J. Cancer 73: 715–718

  • Robertson KD, Jones PA . 2000 Carcinogenesis 21: 461–467

  • Russo J, Russo IH . 1987 The mammary gland. Development, Regulation and Function Neville MC and Daniel CW (eds) New York: Plenum Press pp 67–93

    Book  Google Scholar 

  • Saito Y, Kanai Y, Sakamoto M, Saito H, Ishii H, Hirohashi S . 2001 Hepatology 33: 561–568

  • Tanner JM . 1962 Growth at Adolescence Tanner JM (ed) Oxford: Blackwell Scientific pp 28–39

    Google Scholar 

  • Tate P, Skarnes W, Bird A . 1996 Nat. Genet. 12: 205–208

  • Tate PH, Bird AP . 1993 Curr. Opin. Genet. Dev. 3: 226–231

  • Wade PA, Gegonne A, Jones PL, Ballestar E, Aubry F, Wolffe AP . 1999 Nat. Genet. 23: 62–66

  • Wade PA . 2001 Oncogene 20: 3166–3173

  • Xu GL, Bestor TH, Bourc'his D, Hsieh CL, Tommerup N, Bugge M, Hulten M, Qu X, Russo JJ, Viegas-Pequignot E . 1999 Nature 11: 187–191

  • Yu F, Thiesen J, Stratling WH . 2000 Nucleic Acids Res. 15: 2201–2206

  • Zhou X, Marks PA, Rifkind RA, Richon VM . 2001 Proc. Natl. Acad. Sci. USA. 98: 10572–10577

Download references

Acknowledgements

We are most grateful to Drs Alan Wolffe and Paul Wade for providing MBD2 antibodies. We thank Dr Nicole Dalla Venezia for critical reading of this manuscript. The present work was supported by the Ligue Nationale pour la Recherche contre le Cancer, Comité de Saône et Loire and Comité du Rhône and the Association pour la Recherche contre le Cancer.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robert Dante.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Billard, LM., Magdinier, F., Lenoir, G. et al. MeCP2 and MBD2 expression during normal and pathological growth of the human mammary gland. Oncogene 21, 2704–2712 (2002). https://doi.org/10.1038/sj.onc.1205357

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205357

Keywords

This article is cited by

Search

Quick links